Common fragile sites are preferential targets for HPV16 integrations in cervical tumors

Oncogene

Volumn 22, Issue 8, 2003, Pages 1225-1237

  Thorland, Erik C ^a   Myers, Shannon L ^b   Gostout, Bobbie S ^b   Smith, David I ^b  

^a MAYO GRADUATE SCHOOL   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Cervical cancer; Common fragile sites; Human papillomavirus; RS PCR; Viral integration

Indexed keywords

APHIDICOLIN; NOTCH RECEPTOR;

ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; CHROMOSOME 13P; CHROMOSOME 13Q; CHROMOSOME FRAGILE SITE; CONDYLOMA; DISEASE ASSOCIATION; DNA FLANKING REGION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE CLUSTER; GENE DELETION; GENE DISRUPTION; GENE REARRANGEMENT; GENE SEQUENCE; GENE TARGETING; HUMAN; HUMAN TISSUE; METAPHASE; MOLECULAR PROBE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; UTERINE CERVIX CANCER; VIRUS GENOME; WART VIRUS;

CARCINOMA, SQUAMOUS CELL; CELL TRANSFORMATION, VIRAL; CHROMOSOME FRAGILE SITES; CHROMOSOME FRAGILITY; CHROMOSOMES, ARTIFICIAL, BACTERIAL; CHROMOSOMES, HUMAN; DNA, VIRAL; FEMALE; HUMANS; MUTAGENESIS, INSERTIONAL; NEOPLASM PROTEINS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; SEQUENCE DELETION; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; VIRUS INTEGRATION;

BACTERIA (MICROORGANISMS); DNA VIRUSES; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPES; PAPILLOMAVIRUS; PAPOVAVIRIDAE;

EID: 0037468256     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206170     Document Type: Article

References (61)

1. An WF, Bowlby MR, Betty M, Cao J, Ling HP, Mendoza G, Hinson JW, Mattsson KI, Strassle BW, Trimmer JS and Rhodes KJ. (2000). Nature, 403, 553-556.
2. Arlt MF, Miller DE, Beer DG and Glover TW. (2002). Genes Chromosomes Cancer, 33, 82-92.
3. Baker CC, Phelps WC, Lindgren V, Braun MJ, Gonda MA and Howley PM (1987). J. Virol., 61, 962-971.
4. Bauer-Hofmann R, Borghouts C, Auvinen E, Bourda E, Rosl F and Alonso A. (1996). Virology, 217, 33-41.
5. Becker NA, Thorland EC, Denison SR, Phillips LA and Smith DI. (2002). Oncogene, in press.
6. Burge C and Karlin S. (1997). J. Mol. Biol., 268, 78-94.
7. Cannizzaro LA, Durst M, Mendez MJ, Hecht BK and Hecht F. (1988). Cancer Genet. Cytogenet., 33, 93-98.
8. Capobianco AJ, Zagouras P, Blaumueller CM, Artavanis-Tsakonas S and Bishop JM. (1997). Mol. Cell Biol., 17, 6265-6273.
9. Chen C, Brabham WW, Stultz BG, Frierson Jr HF., Barrett JC, Sawyers CL, Isaacs JT and Dong JT. (2001). Genes Chromosomes Cancer, 31, 333-344.
10. Choo KB, Chen CM, Han CP, Cheng WT and Au LC. (1996). J. Med. Virol., 49, 15-22.
11. Choo KB, Huang CJ, Chen CM, Han CP and Au LC. (1995). Cancer Lett., 93, 249-253.
12. Choo KB, Lee HH, Liew LN, Chong KY and Chou HF. (1990). Virology, 178, 621-625.
13. Choo KB, Pan CC and Han SH. (1987). Virology, 161, 259-261.
14. Crook T, Storey A, Almond N, Osborn K and Crawford L. (1988). Proc. Natl. Acad. Sci. USA, 85, 8820-8824.
15. Cullen AP, Reid R, Campion M and Lorincz AT. (1991). J. Virol., 65, 606-612.
16. Desseyn JL, Guyonnet-Duperat V, Porchet N, Aubert JP and Laine A. (1997). J. Biol. Chem., 272, 3168-3178.
17. Dong JT, Chen C, Stultz BG, Isaacs JT and Frierson Jr HF. (2000). Cancer Res., 60, 3880-3883.
18. Dyson N, Howley PM, Munger K and Harlow E. (1989). Science, 243, 934-937.
19. Ellisen LW, Bird J, West DC, Soreng AL, Reynolds TC, Smith SD and Sklar J. (1991). Cell, 66, 649-661.
20. Gallego MI, Schoenmakers EF, Van de Ven WJ and Lazo PA. (1997). Mol. Carcinog., 19, 114-121.
21. Girard L, Hanna Z, Beaulieu N, Hoemann CD, Simard C, Kozak CA and Jolicoeur P. (1996). Genes Dev., 10, 1930-1944.
22. Glover TW, Coyle-Morris J and Morgan R. (1986). Cancer Genet. Cytogenet., 19, 141-150.
23. Gostout BS, Podratz KC, McGovern RM and Persing DH. (1998). Am. J. Obstet. Gynecol., 179, 56-61.
24. Hecht F. (1988). Cancer Genet. Cytogenet., 31, 17-24.
25. Huang H, Qian C, Jenkins RB and DI S. (1998). Genes, Chromosomes Cancer, 21, 152-159.
26. Inohara N, del Peso L, Koseki T, Chen S and Nunez G. (1998). J. Biol. Chem., 273, 12296-12300.
27. Jeon S, Allen-Hoffmann BL and Lambert PF. (1995). J. Virol., 69, 2989-2997.
28. Ji Y, Eichler EE, Schwartz S and Nicholls RD. (2000). Genome Res., 10, 597-610.
29. Kahn T, Turazza E, Ojeda R, Bercovich A, Stremlau A, Lichter P, Poustka A, Grinstein, S and zur Hausen H. (1994). Cancer Res., 54, 1305-1312.
30. Kainu T, Juo SH, Desper R, Schaffer AA, Gillanders E, Rozenblum E, Freas-Lutz D, Weaver D, Stephan D, Bailey-Wilson J, Kallioniemi OP, Tirkkonen M, Syrjakoski K, Kuukasjarvi T, Koivisto P, Karhu R, Holli K, Arason A, Johannesdottir G, Bergthorsson JT, Johannsdottir H, Egilsson V, Barkardottir RB, Johannsson O, Haraldsson K, Sandberg T, Holmberg E, Gronberg H, Olsson H, Borg A, Vehmanen P, Eerola H, Heikkila P, Pyrhonen S and Nevanlinna H. (2000). Proc. Natl. Acad. Sci. USA, 97, 9603-9608.
31. Kalantari M, Karlsen F, Kristensen G, Holm R, Hagmar B and Johansson B. (1998). Int. J. Gynecol. Pathol., 17, 146-153.
32. Krummel KA, Roberts LR, Kawakami M, Glover TW and Smith DI. (2000). Genomics, 69, 37-46.
33. Lazo PA. (1999). Br. J. Cancer, 80, 2008-2018.
34. Luft F, Klaes R, Nees M, Durst M, Heilmann V, Melsheimer P and von Knebel Doeberitz M. (2001). Int. J. Cancer, 92, 9-17.
35. Mangelsdorf M, Ried K, Woollatt E, Dayan S, Eyre H, Finnis M, Hobson L, Nancarrow J, Venter D, Baker E and Richards RI. (2000). Cancer Res., 60, 1683-1689.
36. McCarthy JV, Ni J and Dixit VM. (1998). J. Biol. Chem., 273, 16968-16975.
37. Mishmar D, Rahat A, Scherer SW, Nyakatura G, Nihzmann B, Kohwi Y, Mandel-Gutfroid Y, Lee JR, Drescher B, Sas DE, Margalit H, Platzer M, Weiss A, Tsui LC, Rosenthal A and Kerem B. (1998). Proc. Natl. Acad. Sci. USA, 95, 8141-8146.
38. Morelli C, Karayianni E, Magnanini C, Mungall AJ, Thorland E, Negrini M, Smith DI and Barbanti-Brodano G. (2002). Oncogene, 21, 7266-7276.
39. Paige AJ, Taylor KJ, Stewart A, Sgouros JG, Gabra H, Sellar GC, Smyth JF, Porteous DJ and JEW. (2000). Cancer Res., 60, 1690-1697.
40. Pecoraro G, Morgan D and Defendi V. (1989). Proc. Natl. Acad. Sci. USA, 86, 563-567.
41. Popescu NC and DiPaolo JA. (1989). Cancer Genet. Cytogenet., 42, 157-171.
42. Popescu NC, Zimonjic D and DiPaolo JA. (1990). Hum. Genet., 84, 383-386.
43. Rangarajan A, Syal R, Selvarajah S, Chakrabarti O, Sarin A and Krishna S. (2001). Virology, 286, 23-30.
44. Reuter S, Bartelmann M, Vogt M, Geisen C, Napierski I, Kahn T, Delius H, Lichter P, Weitz S, Korn B and Schwarz E. (1998). Embo. J., 17, 215-222.
45. Richards RI. (2001). Trends Genet., 17, 339-345.
46. Sarkar G, Turner RT and Bolander ME. (1993). PCR Methods Appl., 2, 318-322.
47. Sastre-Garau X, Favre M, Couturier J and Orth G. (2000). J. Gen. Virol., 81 Pt 8, 1983-1993.
48. Shaulian E and Karin M. (2001). Oncogene, 20, 2390-2400.
49. Smith DI, Huang H and Wang L. (1998). Int. J. Oncol., 12, 187-196.
50. Thome M, Hofmann K, Burns K, Martinon F, Bodmer JL, Mattmann C and Tschopp J. (1998). Curr. Biol., 8, 885-888.
51. Thorland EC, Myers SL, Persing DH, Sarkar G, McGovern RM, Gostout BS and Smith DI. (2000). Cancer Res., 60, 5916-5921.
52. Verma RS and Babu A. (1989). Human Chromosome: Manual of Basic Techniques, First edn. Pergamon Press, Inc.: New York.
53. Vernon SD, Unger ER, Miller DL, Lee DR and Reeves WC. (1997). Int. J. Cancer, 74, 50-56.
54. Wagatsuma M, Hashimoto K and Matsukura T. (1990). J. Virol., 64, 813-821.
55. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ and Munoz N. (1999). J. Pathol., 189, 12-19.
56. Werness BA, Levine AJ and Howley PM. (1990). Science, 248, 76-79.
57. Wilke CM, Hall BK, Hoge A, Paradee W, Smith DI and Glover TW. (1996). Hum. Mol. Genet., 5, 187-195.
58. Yordy JS and Muise-Helmericks RC. (2000). Oncogene, 19, 6503-6513.
59. Yunis JJ and Soreng AL. (1984). Science, 226, 1199-1204.
60. Yunis JJ, Soreng AL and Bowe AE. (1987). Oncogene, 1, 59-69.
61. Zagouras P, Stifani S, Blaumueller CM, Carcangiu ML and Artavanis-Tsakonas S. (1995). Proc. Natl. Acad. Sci. USA, 92, 6414-6418.